Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia

Clinical trial NCT03492515 · UNKNOWN

Trial details

NCT number: NCT03492515
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2018-05-01
Primary completion: 2020-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.